Medpace (MEDP)
(Delayed Data from NSDQ)
$329.35 USD
-0.87 (-0.26%)
Updated Oct 28, 2024 04:00 PM ET
After-Market: $329.54 +0.19 (0.06%) 6:52 PM ET
3-Hold of 5 3
C Value A Growth A Momentum A VGM
Medpace (MEDP) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$356.50 | $404.00 | $305.00 | 7.96% |
Price Target
Based on short-term price targets offered by eight analysts, the average price target for Medpace comes to $356.50. The forecasts range from a low of $305.00 to a high of $404.00. The average price target represents an increase of 7.96% from the last closing price of $330.22.
Analyst Price Targets (8 )
Broker Rating
Medpace currently has an average brokerage recommendation (ABR) of 2.11 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by nine brokerage firms. The current ABR compares to an ABR of 1.89 a month ago based on nine recommendations.
Of the nine recommendations deriving the current ABR, four are Strong Buy, representing 44.44% of all recommendations. A month ago, Strong Buy represented 55.56%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 4 | 6 | 5 | 7 | 7 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 5 | 4 | 4 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.11 | 1.80 | 1.89 | 1.44 | 1.44 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
10/23/2024 | Cowen & Co. | Charles Rhyee | Strong Buy | Strong Buy |
10/23/2024 | Robert W. Baird & Co. | Eric W Coldwell | Strong Buy | Hold |
10/22/2024 | William Blair | Maxwell A Smock | Strong Buy | Strong Buy |
10/22/2024 | Mizuho SecuritiesUSA | Ann K Hynes | Strong Buy | Strong Buy |
10/14/2024 | Atlantic Equities | Jamie Clark | Not Available | Strong Buy |
9/27/2024 | UBS | John N Sourbeer | Strong Buy | Hold |
9/25/2024 | Not Identified | Not Identified | Strong Buy | Hold |
8/1/2024 | Truist Securities | Jailendra Singh | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.11 |
ABR (Last week) | 1.80 |
# of Recs in ABR | 9 |
Average Target Price | $356.50 |
LT Growth Rate | 15.10% |
Industry | Medical Services |
Industry Rank by ABR | 168 of 252 |
Current Quarter EPS Est: | 2.97 |
MEDP FAQs
Medpace Holdings, Inc. (MEDP) currently has an average brokerage recommendation (ABR) of 2.11 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 9 brokerage firms.
The average price target for Medpace Holdings, Inc. (MEDP) is $356.50. The current on short-term price targets is based on 4 reports.
The forecasts for Medpace Holdings, Inc. (MEDP) range from a low of $305 to a high of $404. The average price target represents a increase of $7.96 from the last closing price of $330.22.
The current UPSIDE for Medpace Holdings, Inc. (MEDP) is 7.96%
Based on short-term price targets offered by eight analysts, the average price target for Medpace comes to $356.50. The forecasts range from a low of $305.00 to a high of $404.00. The average price target represents an increase of 7.96% from the last closing price of $330.22.